Back
Day Range
$14.20
$14.92
52-Week Range
$3.50
$25.77
Volume
1,627,964
50D / 200D Avg
$19.78
/
$11.73
Prev Close
$15.03
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -24.8 | 0.3 |
| P/B | 4.1 | 2.9 |
| ROE % | -16.9 | 3.7 |
| Net Margin % | -31.2 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$31.75
+115.7%
Low: $22.00
High: $37.00
Forward EPS
-$1.52
Est. Revenue
57 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$1.60
-$4.15 – -$0.19
|
170 M | 1 |
| FY2029 |
-$2.13
-$5.51 – -$0.25
|
120 M | 1 |
| FY2028 |
-$2.26
-$2.90 – -$1.47
|
38 M | 5 |
Key Takeaways
Debt/Equity of 0.17 — conservative balance sheet
Negative free cash flow of -27.50M
PEG of 0.64 suggests growth is underpriced
Capital efficient — spends only 3.80% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)63.54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-16.94%
ROIC-14.93%
Net Margin-31.23%
Op. Margin-43.83%
Safety
Debt / Equity
0.17
Current Ratio6.12
Interest Coverage0.00
Valuation
P/E Ratio
-24.82
P/B Ratio4.11
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 63.54% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 123.67M | Net Income (TTM) | -38.63M |
| ROE | -16.94% | ROA | -8.61% |
| Gross Margin | 93.24% | Operating Margin | -43.83% |
| Net Margin | -31.23% | Free Cash Flow (TTM) | -27.50M |
| ROIC | -14.93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.17 | Current Ratio | 6.12 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -24.82 | P/B Ratio | 4.11 |
| P/S Ratio | 7.75 | PEG Ratio | 0.64 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 958.61M | Enterprise Value | 867.92M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 123.67M | 75.62M | 0.0 | 0.0 | 0.0 |
| Net Income | -38.63M | -72.70M | -135.35M | -108.50M | -73.96M |
| EPS (Diluted) | -0.46 | -0.98 | -2.63 | -2.30 | -1.59 |
| Gross Profit | 115.32M | 67.50M | -6.22M | 0.0 | 0.0 |
| Operating Income | -54.21M | -81.11M | -143.31M | -112.38M | -72.88M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 448.66M | 438.73M | 303.76M | 342.39M | 366.33M |
| Total Liabilities | 215.60M | 215.80M | 124.51M | 70.98M | 18.81M |
| Shareholders' Equity | 233.06M | 222.94M | 179.25M | 271.41M | 347.52M |
| Total Debt | 39.19M | 42.72M | 46.04M | 47.00M | 0.0 |
| Cash & Equivalents | 129.88M | 224.25M | 128.10M | 54.91M | 346.07M |
| Current Assets | 393.19M | 377.44M | 236.21M | 275.89M | 348.67M |
| Current Liabilities | 64.21M | 156.95M | 46.59M | 25.57M | 16.64M |